Mondrian Investment Partners LTD Gilead Sciences, Inc. Transaction History

Mondrian Investment Partners LTD

$6.01 Billion
Q3 2024

A detailed history of Mondrian Investment Partners LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mondrian Investment Partners LTD holds 12,667 shares of GILD stock, worth $1.14 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

12,667

Previous 12,173 4.06%

Holding current value

$1.14 Million

Previous $835,000 27.07%

% of portfolio

0.02%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$66.59 - $83.99 $32,895 - $41,491	494 Added 4.06%	12,667 $1.06 Million
Q2 2024 Aug 12, 2024	BUY	$63.15 - $72.88 $35,869 - $41,395	568 Added 4.89%	12,173 $835,000
Q1 2024 May 07, 2024	BUY	$71.58 - $87.29 $589,890 - $719,356	8,241 Added 244.98%	11,605 $850,000
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $24,765 - $28,084	338 Added 11.17%	3,364 $272,000
Q1 2023 May 09, 2023	SELL	$77.31 - $88.08 $52,106 - $59,365	-674 Reduced 18.22%	3,026 $251,000
Q3 2022 Oct 21, 2022	BUY	$59.54 - $68.01 $102,944 - $117,589	1,729 Added 87.72%	3,700 $228,000
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $83,105 - $94,694	1,467 Added 291.07%	1,971 $115,000
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $13.2 Million - $16.6 Million	-212,211 Reduced 99.76%	504 $29,000
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $25.3 Million - $29.3 Million	-349,184 Reduced 62.14%	212,715 $16.4 Million
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $19.9 Million - $25.5 Million	-317,952 Reduced 36.14%	561,899 $42 Million
Q4 2019 Feb 06, 2020	BUY	$61.62 - $67.78 $7.79 Million - $8.56 Million	126,344 Added 16.77%	879,851 $57.2 Million
Q3 2019 Nov 04, 2019	SELL	$62.51 - $69.0 $20.9 Million - $23.1 Million	-334,596 Reduced 30.75%	753,507 $47.8 Million
Q2 2019 Aug 07, 2019	SELL	$61.87 - $69.38 $856,218 - $960,149	-13,839 Reduced 1.26%	1,088,103 $73.5 Million
Q1 2019 Apr 17, 2019	BUY	$62.53 - $70.05 $10.6 Million - $11.8 Million	169,158 Added 18.13%	1,101,942 $71.6 Million
Q4 2018 Jan 24, 2019	BUY	$60.54 - $79.0 $10.6 Million - $13.8 Million	174,615 Added 23.03%	932,784 $58.3 Million
Q3 2018 Nov 01, 2018	SELL	$71.28 - $78.92 $11.7 Million - $13 Million	-164,201 Reduced 17.8%	758,169 $58.5 Million
Q2 2018 Jul 25, 2018	BUY	$64.88 - $75.68 $5.3 Million - $6.19 Million	81,763 Added 9.73%	922,370 $65.3 Million
Q1 2018 May 11, 2018	BUY	$72.84 - $88.8 $4.42 Million - $5.38 Million	60,626 Added 7.77%	840,607 $60.7 Million
Q4 2017 Jan 18, 2018	BUY	$71.15 - $83.52 $566,425 - $664,902	7,961 Added 1.03%	779,981 $55.9 Million
Q3 2017 Nov 02, 2017	BUY	$72.11 - $85.47 $55.7 Million - $66 Million	772,020	772,020 $62.5 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mondrian Investment Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Mondrian Investment Partners LTD with notifications on news.

Account

Mondrian Investment Partners LTD Gilead Sciences, Inc. Transaction History